HGHRX Mutual Fund

HGHRX Mutual Fund

NAV$44.36
See how much of HGHRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jan 31, 2026

Net Assets
$17M
Expense Ratio
1.63%
Dividend Yield (Current)
3.40%
Holdings
84
Inception Date
Dec 22, 2006
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.38%
1 Year+31.75%
3 Year+7.12%
5 Year+1.88%
10 Year+7.70%

Asset Allocation

Stocks: 99.67%
Bonds: 0.19%
Cash: 0.14%
See how much of HGHRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson - Common5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc.3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.40%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

HGHRX Mutual Fund Overview

HGHRX Mutual Fund (The Hartford Healthcare Fund Cl R3) is managed by Hartford Funds with $16.7M in net assets. HGHRX expense ratio is 1.63%, holding 84 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2006-12-22.

HGHRX performance shows a YTD return of 4.38%. The 1-year return is 31.75% and the 5-year return is 1.88%. HGHRX dividend yield stands at 3.40%, paid annually.

HGHRX top holdings include Eli Lilly & Co. (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson - Common (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc. (3.8%). Go to all HGHRX holdings, HGHRX sectors, or HGHRX dividends.

HGHRX can be compared against other funds. Use HGHRX overlap to find shared positions, or HGHRX vs another fund for a side-by-side view. HGHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.